Alliance for Pandemic Preparedness

April 23, 2021

Preexisting and New-Onset Diabetes in Patients with COVID-19 Pneumonia

Category:

Topic:

Keywords (Tags):

  • [Pre-print, not peer-reviewed] A single-center study of patients admitted for COVID-19 pneumonia with diabetes (N=176) found that having new-onset diabetes was associated with higher risk of ICU admission and death and a longer time to viral clearance compared to having a preexisting diagnosis of diabetes. Nearly 30% of patients with new-onset diabetes did not have clinical indicators of diabetes after viral clearance, suggesting that reversible, transient inflammatory factors may trigger hyperglycemia in some patients with COVID-19. The authors suggest that the higher incidence of severe outcomes in patients with new-onset diabetes highlights the importance of screening for hyperglycemia in patients hospitalized with COVID-19 at admission.

Laurenzi et al. (Apr 22, 2021). Preexisting and New-Onset Diabetes in Patients with COVID-19 Pneumonia. Pre-print downloaded Apr 23 from https://doi.org/10.1101/2021.04.17.21255548